This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Anticholinergics in nocturnal enuresis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

NICE guidance states (1):

  • anticholinergic treatment alone should not be used alone for the management of bedwetting in children and young people without daytime symptoms
  • an anticholinergic combined with desmopressin should be considered for bedwetting in children and young people who also have daytime symptoms and have been assessed by a healthcare professional with expertise in prescribing the combination of an anticholinergic and desmopressin
  • consider an anticholinergic combined with desmopressin for children and young people who have been assessed by a healthcare professional with expertise in the management of bedwetting that has not responded to an alarm and/or desmopressin and have any of the following:
    • bedwetting that has partially responded to desmopressin alone
    • bedwetting that has not responded to desmopressin alone
    • bedwetting that has not responded to a combination of alarm and desmopressin

Continuation of treatment for children and young people with bedwetting should considered if the bedwetting has partially responded to desmopressin combined with an anticholinergic, as bedwetting may continue to improve for up to 6 months after starting treatment

Consider using repeated courses of desmopressin combined with an anticholinergic in children and young people who have responded to this combination but experience repeated recurrences of bedwetting following previous response to treatment

The adverse reactions of this group of medications include dry mouth and eyes, constipation, flushing, sedation, and cognitive effects (2)

Notes:

  • not all anticholinergics have a UK marketing authorisation for treating bedwetting in children and young people. If a drug without a marketing authorisation for this indication is prescribed, informed consent should be obtained and documented
  • do not offer an anticholinergic combined with imipramine for the treatment of bedwetting in children and young people

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.